Mette Thomsen1, Børge G Nordestgaard2, Jørgen Vestbo3, Peter Lange4. 1. Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 2. Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark; The Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen University Hospital, Frederiksberg, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address: boerge.nordestgaard@regionh.dk. 3. Department of Respiratory Medicine, Odense University Hospital, University of Southern Denmark, Odense, Denmark; Respiratory Research Group, Manchester Academic Health Sciences Centre, University Hospital South Manchester NHS Foundation Trust, Manchester, UK. 4. Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark; The Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen University Hospital, Frederiksberg, Denmark; Respiratory Section, Hvidovre Hospital, Copenhagen University Hospital, Hvidovre, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Public Health, Section of Social Medicine, University of Copenhagen, Copenhagen, Denmark.
Abstract
BACKGROUND: A substantial proportion of patients with chronic obstructive pulmonary disease (COPD) have never smoked. We tested the hypothesis that, in individuals with COPD, never smokers have different characteristics and less severe outcomes of the disease than smokers do. METHODS: We included individuals from the Copenhagen General Population Study, a prospective population study. We identified individuals with COPD spirometrically; that is, as the ratio between forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) under the lower limit of normal (LLN), excluding individuals with self-reported asthma. We examined general characteristics, symptoms, disease severity, and levels of inflammatory biomarkers and α1-antitrypsin at baseline. We assessed risk of lung-related hospital admissions, cardiovascular comorbidities, and all-cause mortality during a median follow-up of 4 years (IQR 2.5-5.6). FINDINGS: Between Nov 26, 2003, and July 29, 2010, 68,501 participants from the Copenhagen General Population Study had lung function measurements and complete information on smoking habits available. Of those, we identified 6623 with COPD and no asthma. Of these, 1476 (22%) were never smokers, 2696 (41%) former smokers, and 2451 (37%) current smokers. For comparison we included 24,529 never smokers without COPD. Never smokers with COPD had different clinical characteristics, fewer symptoms, milder disease, and lower levels of inflammatory biomarkers than did current and former smokers with COPD. During follow-up, HRs for hospital admission due to COPD were 8.6 (95% CI 5.3-14) in never smokers, 30 (22-41) in former smokers, and 43 (32-59) in current smokers compared with never smokers without COPD. HRs for hospital admission due to pneumonia were 1.9 (1.4-2.6) in never smokers, 2.8 (2.3-3.4) in former smokers, and 3.4 (2.9-4.2) in current smokers. For hospital admission due to lung cancer, HRs were 11 (5.7-23) in former smokers and 18 (9.2-35) in current smokers, whereas no cases were noted in never smokers. Furthermore, risk of cardiovascular comorbidities and all-cause mortality was increased in former and current smokers but not in never smokers with COPD. INTERPRETATION: Compared with current and former smokers, never smokers with COPD had different characteristics and milder disease, limited to the lungs. However, morbidity due to lung-related hospital admissions was nonetheless substantial in never smokers with COPD. FUNDING: Herlev Hospital, Copenhagen University Hospital, Copenhagen County Foundation, and University of Copenhagen.
BACKGROUND: A substantial proportion of patients with chronic obstructive pulmonary disease (COPD) have never smoked. We tested the hypothesis that, in individuals with COPD, never smokers have different characteristics and less severe outcomes of the disease than smokers do. METHODS: We included individuals from the Copenhagen General Population Study, a prospective population study. We identified individuals with COPD spirometrically; that is, as the ratio between forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) under the lower limit of normal (LLN), excluding individuals with self-reported asthma. We examined general characteristics, symptoms, disease severity, and levels of inflammatory biomarkers and α1-antitrypsin at baseline. We assessed risk of lung-related hospital admissions, cardiovascular comorbidities, and all-cause mortality during a median follow-up of 4 years (IQR 2.5-5.6). FINDINGS: Between Nov 26, 2003, and July 29, 2010, 68,501 participants from the Copenhagen General Population Study had lung function measurements and complete information on smoking habits available. Of those, we identified 6623 with COPD and no asthma. Of these, 1476 (22%) were never smokers, 2696 (41%) former smokers, and 2451 (37%) current smokers. For comparison we included 24,529 never smokers without COPD. Never smokers with COPD had different clinical characteristics, fewer symptoms, milder disease, and lower levels of inflammatory biomarkers than did current and former smokers with COPD. During follow-up, HRs for hospital admission due to COPD were 8.6 (95% CI 5.3-14) in never smokers, 30 (22-41) in former smokers, and 43 (32-59) in current smokers compared with never smokers without COPD. HRs for hospital admission due to pneumonia were 1.9 (1.4-2.6) in never smokers, 2.8 (2.3-3.4) in former smokers, and 3.4 (2.9-4.2) in current smokers. For hospital admission due to lung cancer, HRs were 11 (5.7-23) in former smokers and 18 (9.2-35) in current smokers, whereas no cases were noted in never smokers. Furthermore, risk of cardiovascular comorbidities and all-cause mortality was increased in former and current smokers but not in never smokers with COPD. INTERPRETATION: Compared with current and former smokers, never smokers with COPD had different characteristics and milder disease, limited to the lungs. However, morbidity due to lung-related hospital admissions was nonetheless substantial in never smokers with COPD. FUNDING: Herlev Hospital, Copenhagen University Hospital, Copenhagen County Foundation, and University of Copenhagen.
Authors: Peter J Castaldi; Marta Benet; Hans Petersen; Nicholas Rafaels; James Finigan; Matteo Paoletti; H Marike Boezen; Judith M Vonk; Russell Bowler; Massimo Pistolesi; Milo A Puhan; Josep Anto; Els Wauters; Diether Lambrechts; Wim Janssens; Francesca Bigazzi; Gianna Camiciottoli; Michael H Cho; Craig P Hersh; Kathleen Barnes; Stephen Rennard; Meher Preethi Boorgula; Jennifer Dy; Nadia N Hansel; James D Crapo; Yohannes Tesfaigzi; Alvar Agusti; Edwin K Silverman; Judith Garcia-Aymerich Journal: Thorax Date: 2017-06-21 Impact factor: 9.139
Authors: Mia Moberg; Palchamy Elango; Luigi Ferrucci; Martijn A Spruit; Emiel F Wouters; Erica P A Rutten Journal: Eur J Clin Invest Date: 2015-08-07 Impact factor: 4.686
Authors: Elizabeth C Oelsner; Pallavi P Balte; Patricia A Cassano; David Couper; Paul L Enright; Aaron R Folsom; John Hankinson; David R Jacobs; Ravi Kalhan; Robert Kaplan; Richard Kronmal; Leslie Lange; Laura R Loehr; Stephanie J London; Ana Navas Acien; Anne B Newman; George T O'Connor; Joseph E Schwartz; Lewis J Smith; Fawn Yeh; Yiyi Zhang; Andrew E Moran; Stanford Mwasongwe; Wendy B White; Sachin Yende; R Graham Barr Journal: Am J Epidemiol Date: 2018-11-01 Impact factor: 4.897
Authors: Daniel Mølager Christensen; Matthew Phelps; Thomas Gerds; Morten Malmborg; Anne-Marie Schjerning; Jarl Emanuel Strange; Mohamad El-Chouli; Lars Bruun Larsen; Emil Fosbøl; Lars Køber; Christian Torp-Pedersen; Suneela Mehta; Rod Jackson; Gunnar Gislason Journal: Eur Heart J Open Date: 2021-08-02
Authors: Jacob Louis Marott; Truls Sylvan Ingebrigtsen; Yunus Çolak; Jørgen Vestbo; Peter Lange Journal: Am J Respir Crit Care Med Date: 2020-07-15 Impact factor: 21.405